Sanara MedTech receives Biasurge contract from Vizient

Sanara MedTech (SMTI) announced that its Biasurge product has received a technology contract from Vizient. “We are pleased to see Vizient award this new Innovative Technology contract for Biasurge based on the recommendation of hospital experts, reflecting the differentiated nature of this surgical technology,” said Seth Yon, Sanara MedTech’s president and CEO. “Biasurge’s no-rinse irrigation solution enables surgeons to cleanse the wound bed more efficiently than with saline alone, and its antimicrobial preservative provides broad-spectrum antimicrobial effectiveness in the irrigation solution.”